Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea · Delayed Price · Currency is KRW 13,730
-220 (-1.58%)
Apr 2, 2026, 3:30 PM KST
KRX:271980 Revenue
In the year 2025, Jeil Pharmaceutical Co.,Ltd had annual revenue of 567.24B KRW, down -19.49%. Jeil Pharmaceutical Co.,Ltd had revenue of 131.83B in the quarter ending December 31, 2025, a decrease of -29.34%.
Revenue
567.24B
Revenue Growth
-19.49%
P/S Ratio
0.35
Revenue / Employee
598.99M
Employees
947
Market Cap
200.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 567.24B | -137.30B | -19.49% |
| Dec 31, 2024 | 704.54B | -21.85B | -3.01% |
| Dec 31, 2023 | 726.39B | 4.16B | 0.58% |
| Dec 31, 2022 | 722.23B | 21.54B | 3.07% |
| Dec 31, 2021 | 700.69B | 9.37B | 1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 959.01B |
| Suheung | 722.31B |
| Daewon Pharmaceutical | 590.70B |
| Samjin Pharmaceuticals | 274.03B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| Kyongbo Pharmaceutical | 264.10B |
| JW Lifescience | 257.83B |
| Whan In Pharm | 255.21B |